<!DOCTYPE html><html><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1"><link rel="icon" href="/favicon.png"><link rel="alternate" type="application/rss+xml" title="【数字科技】 – 人工智能，大数据，云计算，区块链，教育培训领域" href="https://jysperm.me/atom.xml"><link rel="stylesheet" href="/styles.css"><title>2018年医疗行业五大重要投资预测 | 【数字科技】 – 人工智能，大数据，云计算，区块链，教育培训领域</title></head><body><div class="container"><div class="columns page-header"><h1>【数字科技】 – 人工智能，大数据，云计算，区块链，教育培训领域</h1></div><div class="columns"><div class="navigation"><nav class="menus-main"><a href="/" class="favicon"><img alt="【数字科技】 – 人工智能，大数据，云计算，区块链，教育培训领域" src="/favicon.png"></a><a href="/">首页</a></nav></div></div><div class="columns"><div class="block-body column three-fourths"><article><header><small class="right"><a target="_blank" href="null_posts%2F1426918566.md">查看源代码</a></small><h1>2018年医疗行业五大重要投资预测</h1></header><div class="article-meta clearfix"><time class="left">2017-11-22</time><ul class="tags left"><li><a href="/categories/uncategorized/">uncategorized</a></li></ul><ul class="tags right"></ul></div><div class="markdown-body"><p>专业投资公司Thessalus Capital预测，2018年医疗行业这五个领域值得投资……</p>
<p>医疗业的迅猛发展越来越引发投资热潮。所谓投资有风险，入市需谨慎。专业投资公司Thessalus Capital（塞萨鲁斯资本管理公司）对医疗业的发展前景及其潜在投资愿景进行了预测，供投资者参考。</p>
<ol>
<li>疑难杂症呈上升趋势</li>
</ol>
<p>一直以来，人们习惯于关注那些影响人群较多的病症，而不是疑难杂症。现在情况有所改观。虽然受这些罕见病、慢性病和综合症影响的人群不超过20万人，但此类病症正逐渐引起社会关注。因业内竞争少，治疗方法少且时间长等因素，治疗这些疾病成为有利可图的产业。</p>
<p>对之前“无药可选”的患者来说，这当然是件好事，但新型药品也会因缺乏竞争而价格高昂。Thessalus Capital主要合伙人Mitchell Ng说：“聪明的投资者应着眼于正在研制罕见病专用药的厂家。这些公司的市值，无论高低，都有巨大的升值空间。”</p>
<p>小贴士：投资者可关注研制罕见病治疗药物的公司。</p>
<ol>
<li>药企并购增多</li>
</ol>
<p>未来十年，价值170亿美元的畅销药专利将到期。这些制药公司需另辟蹊径、弥补专利到期带来的损失。然而，研发新药不仅费时费力，而且其药效尚不确定。虽然制药公司不会停下研发新药的脚步，但会有越来越多的公司通过收购实现发展。</p>
<p>Ng说：“未来可能会有越来越多像辉瑞这样资本雄厚的大公司收购小药厂，而后者正在研制的药物很有市场。”大公司可通过市场营销、再造品牌、生产过程、提升生产和销售效率以及贴牌，帮助小企业加快发展。</p>
<p>小贴士：投资者可查阅药企相关交易流程和并购协议，不仅限于临床试验。</p>
<ol>
<li>技术新突破</li>
</ol>
<p>分子工程和基因编辑技术的突破性成果，预示着制药业将迎来突飞猛进的发展。以嵌合抗原受体T细胞免疫疗法（CAR-T）和CRISPR-CAS9基因编辑技术就是两个例子。CRISPR技术是通过编辑单个细胞的遗传物质，切除致病基因。这种技术有望治愈囊肿性纤维化（Cystic Fibrosis）、肌肉萎缩症（Muscular Dystrophy）和肥厚型心肌病（Hypertrophic Cardiomyopathy）等疾病。CAR-T技术在治疗癌症方面已经有了很大进展。</p>
<p>Ng说：“CAR-T技术可利用患者自身的免疫细胞来清除癌细胞，从而实现个性化治疗。”</p>
<p>另一个值得投资者关注的是区块链技术。这种技术应用于医疗领域，可以使患者自己掌握医疗数据。区块链技术可以保存个人医疗的历史数据，便于个人就诊和做健康规划时有据可寻。</p>
<p>Bowhead Health是一家已将区块链技术应用于生物测试的公司，其首席执行官Rhea Mehta说：“区块链技术本质上是一个去中心化的数据库。如果能证明该技术在金融领域的应用是可靠安全的，那它必将成为电子病历体系中不可缺少的技术。运用区块链技术整合医疗数据后，将大大提升病历使用价值。”</p>
<p>小贴士：在上述两种技术投资，并注重这两个领域研发的公司值得关注。</p>
<ol>
<li>仿制药增加</li>
</ol>
<p>原研药专利到期后，会有更多的仿制药上市。当然了，一边是社会和政界强烈要求控制过高的药品成本，一边是制药业强烈要求保护自己的利益。未来几年，美国FDA可能会出台更有利的政策，推动仿制药发展。这意味着更多的仿制药会批准上市，药价也会相应下降。另外，生产非处方药的传统制药公司，也会因害怕失去客户而不得不进行创新。美国制药公司Genexa总裁Max Spielberg认为：“许多非处方药都是过时的老牌子，只有不断进行创新，才能满足消费者的需求。”</p>
<p>小贴士：关注仿制药生产厂家动态，尤其在实施新政策时，要特别注意。</p>
<ol>
<li>亚洲市场需求增长</li>
</ol>
<p>亚洲崛起带动了经济迅猛发展。为满足市场需求，亚洲也需要像发达国家一样的药品和医疗器械制造能力。中国医疗市场目前占全球份额的四分之一，这一比例将继续提高，并带来无限商机。</p>
<p>值得一提的是，亚洲医疗保险业水平不高，尚待充分开发。Ng认为，未来中国会有更多的商业保险机构参与到国家健康行动计划中来，其医疗业也将获得蓬勃发展。</p>
<p>小贴士：可投资纽交易所上市的中国医疗企业以及中国医疗保险初创公司。</p>
</div></article></div><div class="block-sidebar column one-fourth"><div class="widget tags"></div><div class="widget archives"><ul class="archive-list"><li class="archive-list-item"><a class="archive-list-link" href="/archives/2018/01/">January 2018</a><span class="archive-list-count">6</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/12/">December 2017</a><span class="archive-list-count">17</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/11/">November 2017</a><span class="archive-list-count">28</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/10/">October 2017</a><span class="archive-list-count">7</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/08/">August 2017</a><span class="archive-list-count">9</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/07/">July 2017</a><span class="archive-list-count">1</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/06/">June 2017</a><span class="archive-list-count">24</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/05/">May 2017</a><span class="archive-list-count">3</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/04/">April 2017</a><span class="archive-list-count">8</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/02/">February 2017</a><span class="archive-list-count">17</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2017/01/">January 2017</a><span class="archive-list-count">54</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/12/">December 2016</a><span class="archive-list-count">9</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/11/">November 2016</a><span class="archive-list-count">27</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/10/">October 2016</a><span class="archive-list-count">15</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/09/">September 2016</a><span class="archive-list-count">73</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/08/">August 2016</a><span class="archive-list-count">40</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/07/">July 2016</a><span class="archive-list-count">254</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/06/">June 2016</a><span class="archive-list-count">7</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/05/">May 2016</a><span class="archive-list-count">27</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/04/">April 2016</a><span class="archive-list-count">64</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/03/">March 2016</a><span class="archive-list-count">1</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2016/01/">January 2016</a><span class="archive-list-count">7</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/12/">December 2015</a><span class="archive-list-count">16</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/11/">November 2015</a><span class="archive-list-count">4</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/10/">October 2015</a><span class="archive-list-count">2</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/09/">September 2015</a><span class="archive-list-count">77</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/08/">August 2015</a><span class="archive-list-count">1</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/07/">July 2015</a><span class="archive-list-count">106</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/06/">June 2015</a><span class="archive-list-count">48</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/05/">May 2015</a><span class="archive-list-count">308</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/04/">April 2015</a><span class="archive-list-count">23</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2015/02/">February 2015</a><span class="archive-list-count">51</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/12/">December 2014</a><span class="archive-list-count">25</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/11/">November 2014</a><span class="archive-list-count">4</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/10/">October 2014</a><span class="archive-list-count">106</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/09/">September 2014</a><span class="archive-list-count">39</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/08/">August 2014</a><span class="archive-list-count">6</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/07/">July 2014</a><span class="archive-list-count">25</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/06/">June 2014</a><span class="archive-list-count">55</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/05/">May 2014</a><span class="archive-list-count">18</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/04/">April 2014</a><span class="archive-list-count">46</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/03/">March 2014</a><span class="archive-list-count">37</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/02/">February 2014</a><span class="archive-list-count">14</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2014/01/">January 2014</a><span class="archive-list-count">50</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2013/12/">December 2013</a><span class="archive-list-count">13</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2013/10/">October 2013</a><span class="archive-list-count">104</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2013/07/">July 2013</a><span class="archive-list-count">52</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2013/06/">June 2013</a><span class="archive-list-count">39</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2013/05/">May 2013</a><span class="archive-list-count">79</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2013/04/">April 2013</a><span class="archive-list-count">23</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2013/03/">March 2013</a><span class="archive-list-count">16</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2013/02/">February 2013</a><span class="archive-list-count">12</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2012/11/">November 2012</a><span class="archive-list-count">19</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2012/10/">October 2012</a><span class="archive-list-count">19</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2012/09/">September 2012</a><span class="archive-list-count">16</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2012/08/">August 2012</a><span class="archive-list-count">16</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2012/07/">July 2012</a><span class="archive-list-count">8</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2012/06/">June 2012</a><span class="archive-list-count">13</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2012/05/">May 2012</a><span class="archive-list-count">11</span></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2012/01/">January 2012</a><span class="archive-list-count">1</span></li></ul></div><div class="widget text-content"><p>该博客使用基于 &nbsp;<a href="http://hexo.io">Hexo</a>&nbsp; 的 &nbsp;<a href="https://github.com/jysperm/hexo-theme-simpleblock">simpleblock</a>&nbsp; 主题。博客内容使用 &nbsp;<a href="http://creativecommons.org/licenses/by-nc-sa/3.0/cn">CC BY-NC-SA 3.0</a>&nbsp; 授权发布。最后生成于 2018-02-03.</p></div></div></div></div></body></html>